Impact of the NOGG and NOF Guidelines on the Indication of Bone Mineral Density in Routine Clinical Practice

Journal of Clinical Densitometry

Volumn 18, Issue 4, 2015, Pages 533-538

  Kyriakos, Georgios ^a   Vidal Casariego, Alfonso ^a   Fernández Martínez, María Nélida ^b   Blanco Suárez, María Dolores ^a   Ballesteros Pomar, María D ^a   Cano Rodríguez, Isidoro ^a  

^a Gerencia Regional de Salud de Castilla y León   (Spain)

^b UNIVERSITY OF LEÓN   (Spain)

Author keywords

Bone density; FRAX; NOF; NOGG; Osteoporosis

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRAGILITY FRACTURE; HIGH RISK POPULATION; HIP FRACTURE; HUMAN; INTERMEDIATE RISK POPULATION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS;

AGED; BONE DENSITY; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; OSTEOPOROSIS; PRACTICE GUIDELINES AS TOPIC;

EID: 84952870669     PISSN: 10946950     EISSN: 15590747     Source Type: Journal    
DOI: 10.1016/j.jocd.2015.08.001     Document Type: Article

References (22)

1. González López-Valcárcel B., Sosa Henríquez M. Estimación del riesgo de fractura osteoporótica a los 10 años para la población española. Med Clin (Barc) 2013, 140(3):104-109.
2. Reginster J.Y., Burlet N. Osteoporosis: a still increasing prevalence. Bone 2006, 38(2 Suppl 1):S4-S9.
3. Hernlund E., Svedbom A., Ivergård M., et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 2013, 8(1-2):136.
4. Bouza C., López T., Palma M., et al. Hospitalised osteoporotic vertebral fractures in Spain: analysis of the national hospital discharge registry. Osteoporos Int 2007, 18(5):649-657.
5. National Osteoporosis Foundation. 2014 Clinician's Guide to Prevention and Treatment of Osteoporosis. Available at: http://nof.org/files/nof/public/content/file/2791/upload/919.pdf. Accessed May 28, 2015.
6. Schousboe J.T., Shepherd J.A., Bilezikian J.P., et al. Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry. J Clin Densitom 2013, 16(4):455-466.
7. Instituto Nacional de Estadística. Datos de la población española en el año 2009. Available at: http://www.ine.es. Accessed February 12, 2015.
8. Emanuel E., Tanden N., Altman S., et al. A systemic approach to containing health care spending. N Engl J Med 2012, 367(10):949-954.
9. Mold J.W., Stein H.F. The cascade effect in the clinical care of patients. N Engl J Med 1986, 314(8):512-514.
10. Schnatz P.F., Marakovits K.A., Dubois M., et al. Osteoporosis screening and treatment guidelines: are they being followed?. Menopause 2011, 18(10):1072-1078.
11. Kanis J.A., McCloskey E.V., Johansson H., et al. Case finding for the management of osteoporosis with FRAX-assessment and intervention thresholds for the UK. Osteoporos Int 2008, 19(10):1395-1408.
12. González-Macías J., Marin F., Vila J., et al. Probability of fractures predicted by FRAX® and observed incidence in the Spanish ECOSAP Study cohort. Bone 2012, 50(1):373-377.
13. TM tool in Spain. BMC Musculoskelet Disord 2011, 12:30.
14. Azagra R., Zwart M., Aguyé A., et al. Precauciones necesarias al utilizar los umbrales predictivos de la herramienta FRAX ® en la población española para decidir la necesidad de solicitar una densitometría ósea axial. Aten Primaria 2012, 44(3):183-184.
15. Compston J., Bowring C., Cooper A., et al. Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas 2013, 75(4):392-396.
16. Ruskey Frank, Savage Carla D. The search for simple symmetric Venn diagrams. Not Am Math Soc 2006, 53(11):1304-1311.
17. Bolland M.J., Grey A. Disparate outcomes from applying U.K. and U.S. osteoporosis treatment guidelines. J Clin Endocrinol Metab 2010, 95(4):1856-1860.
18. Bridges M.J., Ruddick S. Ability of FRAX/NOGG guidelines to identify patients sustaining low trauma fractures. Rheumatology (Oxford) 2010, 49(2):391-392.
19. Sanfélix-Genovés J., Catalá-López F., Sanfélix-Gimeno G., et al. Variabilidad en las recomendaciones para el abordaje clínico de la osteoporosis. Med Clin (barc) 2014, 142(1):15-22.
20. Leslie W.D., Lix L.M., Johansson H., et al. Selection of women aged 50-64 yr for bone density measurement. J Clin Densitom 2013, 16(4):570-578.
21. Hurtado I., Sanfélix-Gimeno G., Baixauli-Pérez C., et al. Impact on the population of different bone mineral density testing criteria and appropriateness of densitometries in the ESOSVAL cohort, Spain. J Clin Endocrinol Metab 2014, 99(1):142-150.
22. Del Río Barquero L., Tebé Cordomi C., Johansson H., et al. Evaluación del riesgo absoluto de fractura mediante herramienta FRAX® en una cohorte española. Rev Osteoporos Metab Miner 2011, 3:285-294.